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ABSTRACT 
G-CSF in individual follicular fluids correlates with the potential of the corresponding embryo to result in a live 
birth after transfer in IVF. To evaluate the requirements for routine follicular fluid G-CSF quantification, we 
compared follicular fluid G-CSF measurements made with two multiplexed microbead assays purchased from 
Bio-Rad Laboratories and R&D Systems, and a commercial G-CSF ELISA (R&D Systems). Individual follicular 
fluids (n = 139) associated with transferred embryos were analysed to determine cytokine profile and the fate of 
each transferred embryo was recorded. The effect of multiplexing as well as comparison of the respective 
performances of the microbead assay with a flow cytometry assay was explored. Multivariable logistic 
regression analysis was performed and receiver operating characteristic (ROC) analysis was used to determine 
the performance and sensitivity/specificity of each method for individual follicular fluids. Covariate factors 
known to influence IVF outcome such as age, serum oestradiol and embryo score were systematically integrated 
in each analysis. The quantification of follicular fluid G-CSF using microbead assay methodologies, but not 
ELISA, yielded results showing the utility of follicular fluid G-CSF as a biomarker predictive of a successful 
delivery (Auroc: 0.77 [0.68-0.84] (p = 0.003) and 0.75 [0.66-0.82] (p = 0.004) for Bio-Rad and R&D Systems 
microbead assays respectively), whereas follicular fluid G-CSF values quantified by ELISA were not predictive 
(Auroc:0.61 [0.52-0.70] p = 0.84). Microbead assay and flow cytometry appeared similarly efficient for 
quantifying follicular fluid G-CSF and multiplex versus single-plex assays did not influence the reliability of 
quantification. 
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1. Introduction 
In previous studies, we simultaneously measured with a multiplex bead-based immunoassay 27 cytokines and 
chemokines in each follicular fluid collected from individual follicles after either ovarian hyperstimulation or 
monitored natural cycles. Each follicular fluid analysed was the source of an oocyte subsequently fertilized and 
transferred (Lédée et al, 2008, 2010). We demonstrated that the level of granulocyte colony-stimulating factor 
(G-CSF) in individual follicular fluid samples was correlated with the birth potential of the corresponding 
embryo. Studies using Western blotting and immunochemistry techniques have identified G-CSF protein and its 
receptor in the ovary, mainly in the granulosa cells of the follicles, and found that it surges at ovulation (Salmassi 
et al., 2004; Yanagi et al., 2002). Salmassi et al. (2004) reported an increase in G-CSF levels 10 days after 
ovulation in the serum of successful hyperstimulated and natural IVF/ICSI cycles (Salmassi et al., 2005). 
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Assessing the full potential of each individual oocyte or embryo to develop and successfully implant is desirable 
in assisted reproduction. It is the key to decreasing the mortality and morbidity generated by multiple 
pregnancies and also the adverse psychological effects of explained negative results. During ART cycles, only 
approximately 5% of fresh oocytes result in a baby (Patrizio and Sakkas, 2009). Morphological parameters for 
non-invasive quality embryo assessment have been developed, although their biological relevance has recently 
been re-evaluated (Guerif et al., 2007). 
In determining the utility of G-CSF as a biomarker for oocyte developmental competence and implantation 
potential, the choice of the technology as well as the validation of standard operating procedures is likely to be 
important. The major question remaining before routine application in IVF programs is the nature of the most 
appropriate technique for detecting G-CSF in follicular fluid, in order to reliably predict the implantation 
potential of the resulting embryo. 
2. Materials and methods 
2.1. Study protocol 
2.1.1.   Patients 
From September 2005 through March 2007, we prospectively recruited 84 women undergoing their first attempt 
of fertility treatment by intracytoplasmic sperm injection (ICSI). Each patient was included only once. The 
choice to only include ICSI patients was related to the treatment protocol, which aimed to define the cytokine 
content of individual follicular fluids in morphologically mature oocytes at the time of collection. All patients 
gave fully informed consent, and the Institutional Review Board (Comité Consultatif de Protection des 
Personnes, Poissy-St Germain en Laye) approved this investigation. 
2.1.2.   Treatments 
Ovarian hyperstimulation protocols were selected by each treating physician. The response to the stimulation 
was monitored by serial blood tests together with ultrasound assessment of follicular and endometrial growth. 
Ovulation was triggered when at least 4 follicles had reached 16 mm. We classified the responses to ovarian 
stimulation into three categories: (1 ) low response; serum oestradiol below 1500 pg/ml on the day ovulation was 
triggered, (2) moderate responders; serum oestradiol between 1500 and 3500 pg/ml, and (3) high responders; 
serum oestradiol over 3500 pg/ml. 
The oocytes were retrieved by aspiration 35-36 h after triggering ovulation, using general or local anaesthesia 
and vaginal ultrasound guidance, with the aid of an individual 10 ml syringe for each follicle as previously 
described (Lédée et al., 2008). Oocytes were collected individually and the cumulus and corona cells were 
removed by incubation in 80 IU hyaluronidase (Fertipro, JCD, France). The oocytes were injected with a single 
sperm in a 5 µl droplet of Ferticult Hepes (JCD, France) under standard conditions, and individually cultured in a 
40 µl microdroplet of ISM1 (Medicult, France) under oil at 37°C in a 5% CO2 humidified atmosphere. On day 2, 
the embryos were analysed to measure (a) blastomere fragmentation (grade 1: 10% or less; grade 2, 10-30%; 
grade 3, 30-50%; grade 4, over 50%, and the grade was marked down when blastomeres were unequal in size) 
and (b) number of blastomeres. An embryo score, calculated as the number of blastomeres × (5 - grade), was 
attributed to each embryo (Steer et al., 1992). The optimal category was defined as those with 4-5 cells on day 2, 
10% or less of fragmentation and equal blastomere size. 
2.1.3. Follicular fluid samples 
The presence of an oocyte in each follicular fluid sample was assessed immediately, and those samples without 
an oocyte were discarded. The samples were initially stored at -20°C and then at -80°C until they were assayed. 
Only those follicular fluid samples corresponding to embryos transferred on day 2 were analysed. From 162 
embryos transferred on day 2, 139 follicular fluids were analysed. Each follicular fluid sample was blinded, 
identified only by patient number, stimulation number, and oocyte number within the cohort. Attaching names 
(and therefore results) to the numbers required a key not available to those performing the test (Medifirst SA, 
Guyancourt, France). Follicular fluids from n = 139 follicles were thawed and analysed, without any other 
manipulation or dilution, by two multiplexed microbead assays purchased from two different companies (R&D 
Systems, Minneapolis, MN, USA and Bio-Rad Laboratories, Hercules, CA, USA), as well as by a standard 
commercial solid-phase ELISA for G-CSF (Quantikine G-CSF kit, R&D Systems, Wresbaden, Germany). 
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2.2. Methods used to quantify cytokines in follicular fluids 
Both multiplexed microbead assays were tested to simultaneously measure multiple analytes in individual 
follicular fluids by flow cytometric resolution of spectrally distinct microspheres coupled with capture molecules 
and reporter fluorochromes bound to detection antibodies. A Luminex system (Luminex Map Technology) was 
used to read concentrations of cytokines, chemokines and growth factors. The multiplexed microbead assay from 
Biorad detected IL-1α, IL-1Rα, IL-2, IL-4, IL-5, IL-6, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-17, IFNα TNFα 
G-CSF, GM-CSF, VEGF, PDGF, FGF, IP-10, MCP-1, CCL5, eotaxin, MIP-1α and MIP-1β. A single-plex 
microbead assay (also purchased from Bio-Rad®) measured G-CSF alone. The multiplexed microbead assay 
from R&D Systems® measured IL-1α, IL-1β, ΓL-1Rα, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-17, TNFα, IFN7, 
G-CSF, GM-CSF, VEGF, MIP-1α, MIP-β, RANTES and MCP-1. Each assay was performed according to the 
manufacturer instructions. 
The limits of detection for follicular fluid G-CSF (defined as mean ±2 SD of blank samples, where G-CSF was 
not present) were 5.3 ± 8pg/ml (range = 0-13 pg/ml) for the Bio-Rad multiplexed microbead assay and 3.5 ± 3 
pg/ml (range = 0.5-6.5 pg/ml) for the R&D Systems multiplexed microbead assay. The % CV for the Bio-Rad 
multiplex bead-based assay and for the R&D Systems multiplex bead-based assay is <5% for intra-assay 
variation and <10% for interassay variation. In the single-plex microbead assay, the lower limit of G-CSF 
detection was 1.7 pg/ml. 
The G-CSF content of individual follicular fluids was also assayed in the commercial ELISA according to the 
manufacturer instructions. All samples, standards and controls were assayed in duplicate. Precision was <5% for 
intra-assay variation and <10% for inter-assay variation with a detection limit of 20 pg/ml. 
For the flow cytometric assay, levels of G-CSF were assayed using the Cytometric Bead Array Human Soluble 
Protein Flex set (BD Biosciences, cat #558-264) according to the manufacturer instructions. Flow cytometry 
analysis was performed using a FACSCanto II (BD Biosciences) and data were analysed with FCAP (BD 
Biosciences) software. The detection limit was 1.6 pg/ml and precision was <3% for intra-assay variation and 
<9% for inter-assay variation. 
2.3. Statistical analysis 
For the study cohort a mean of 2 embryos were replaced. Thus we were only able to define for each sample its 
corresponding implantation rate. Implantation rate is defined as the number of intrauterine gestational sacs 
observed by ultrasound at seven weeks of amenorrhea, expressed as a ratio of the number of transferred 
embryos. The delivery rate was defined as the ratio of the number of babies born to the number of embryos 
transferred. Embryos transferred (and their corresponding follicular fluids) were classified according to three 
categories : embryos which did not implant (n = 104), embryos which definitely implanted (n = 13) (2 embryos 
replaced resulting in twin fetuses, or 1 embryo replaced resulting in a singleton fetus) and a third category in 
which a probability of implantation was defined (n = 22) (for example, 2 embryos replaced resulting in a 
singleton fetus). To identify predictive factors of subsequent birth, multivariable logistic regression analysis was 
performed and receiver operating characteristic (ROC) analysis was used to determine the performance and the 
sensitivity/specificity for individual follicular fluids for which the outcome was clearly defined as either no 
delivery (n = 104) or definite delivery (n = 13). Covariate factors known to influence the IVF outcome such as 
age, number of previous failed IVF attempts and embryo score were systematically integrated in each analysis, in 
order to exclude possible bias in the interpretation. A p-value > 0.1 was used as a criterion for exclusion 
according to the literature on multivariate prognostic modeling. The following thresholds were used to interpret 
area under the ROC curve (AUCROC): 0.9-1, perfect separation; 0.8-0.9, excellent discrimination; 0.7-0.8, 
acceptable discrimination; 0.6-0.7, poor discrimination; 0.5-0.6, no discrimination (MedCalc for Windows, 
version 9.2.0.0 software, MedCalcSoftware, Mariakerke, Belgium). The AUroc methodology also allowed us to 
define the threshold of optimal sensitivity/specificity according to each method of quantification in regard to the 
delivery outcome. We then compared the implantation rate of the entire cohort of embryos transferred (n = 139) 
according to their predefined category of G-CSF concentrations by ANOVA test. A p-value of <0.05 was 
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Table 1 Patient profile and response to ovarian stimulation in the three predefined groups of embryos. 
Parameter No implantation 
[IR = 0] 
Definite implantation 
[IR = 1] 
Likely implantation 
[0 < IR < 1] 
p-Valuea 
Number of patients 62 7 15  
Age (years) 32.35 30.4 29.6 0.05 
Protocol of ovarian hyperstimulation % 
antagonist/%agonist 
16/84 14/86 16/84 NS 
Oestradiol in serum on day HCG administration 
(pg/ml)b 
2485 1898 2350 0.4 
Number of oocytes collectedb 8.56 8.7 8.86 0.96 
Number of embryos obtained at day 2b 5 4 4.6 0.4 
Mean number of embryos transferred on day 2b 2 1.85 1.9 0.4 
% of twins 0 86 (6/7) 0 (0/22) 0.0001 
FF analysed by both multiplexed microbead 
assays and ELISA 
104 13 22  
FF, follicular fluids.  
a Data were analysed by ANOVA.  
b Data are mean values. 
 
3. Results 
3.1. ICSI results, pregnancy rates and delivery rates 
The patient profiles, response to stimulation and IVF/ICSI outcome are detailed in Table 1 for the three 
predefined categories of outcome (no implantation, definite implantation and likely implantation). No significant 
difference was observed between the groups of embryos which implanted or not for the age of patients, their 
respective response to ovarian stimulation, number of oocytes collected or number of embryos transferred. 
Overall, the mean implantation and delivery rates were 17.3% per embryo. No miscarriage or non-progressing 
biochemical pregnancies were observed in the present cohort (28 gestational sacs for 162 transferred embryos). 
Per patient, the mean clinical pregnancy and live birth rates were 25% (21/84), and the multiple pregnancy rate 
was 33% (7/21). 
3.2. The cytokine/chemokine/growth factor content of follicular fluid samples 
In the Bio-Rad multiplexed microbead assay IL-1Rα, IL-4, IL-6, IL-8, IL-12, IL-13, G-CSF, VEGF, MCP-1, and 
eotaxin were detected in all follicular fluid samples, while IL-1α, IL-5, IL-7 and IL-17 were detected in none or 
less than 5% of the samples. IL-15, PDGF, CCL-5, IFN7, IL-9, MIP-1β, IL-10, GM-CSF, IP-10, IL-2, FGF, 
TNFα, MIPα and CCL5 were detected in 95, 88, 82, 81, 81, 78, 62, 59, 58, 38, 36 and 10% of the follicular fluid 
samples respectively. 
In the R&D Systems microbead assay IL-1Rα, IL-4, IL-6, IL-8, G-CSF, MIP-1β, CCL-5, MCP-1 and VEGF 
were detected in all follicular fluid samples , while IL-1α, IL-2 and IL-17 were detected in none or less than 5% 
of the samples MIP-1α, TNFα, IFN7, IL-10, GM-CSF and IL-5 were detected in 75, 68, 59, 30, 25 and 18% of 
the samples respectively. 
In the standard G-CSF ELISA assay, G-CSF was detected in all samples. 
In the multiplexed microbead assays from Bio-Rad and R&D Systems, the means of follicular G-CSF were 18.7 
and 21.6 pg/ml respectively, ranging from 0 to 37 pg/ml and 0 to 50.7 pg/ml respectively, with a normal 
distribution in both cases. In the ELISA, the mean value of follicular G-CSF was 130 pg/ml, ranging from 47 to 
313 pg/ml, with an abnormal distribution (Agostino-Pearson test). 
Follicular fluid G-CSF concentrations were significantly different between embryos, which led to implantation 
versus no implantation, in both of the multiplexed microbead assays from Bio-Rad (p = 0.01) and R&D Systems 
(p = 0.04), but there was no difference between these groups detected by ELISA (p = 0.5) (Table 2). 
Surprisingly, most of the cytokines, chemokines and growth factors were not correlated with each other if 
assessed by the R&D Systems or Bio-Rad multiplexed microbead assays, except for G-CSF, GM-CSF and 
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VEGF values, which did show correlations. Furthermore, the follicular fluid G-CSF evaluated by the two 
multiplexed microbead assays from R&D Systems and Bio-Rad were correlated (r = 0.38, p < 0.001). The 
follicular fluid G-CSF evaluated by the multiplexed microbead assay and the ELISA from R&D Systems were 
also correlated (r = 0.43, p < 0.0001), but no correlation was observed between the G-CSF data evaluated by 
multiplexed microbead assay from Bio-Rad and the R&D Systems ELISA. 
 
Table 2 Concentrations of follicular fluid G-CSF in the three predefined groups of embryos accordingly to each 
of three methods of quantification. 
Parameter No implantation 
[IR = 0] 
Definite implantation 
[IR = 1] 
Likely implantation 
[0 < IR < 1] 
p-Valuea 
FF G-CSF (pg/ml) Multiplexed microbead assay 
(Biorad)b 
17.6 22.9 21.3 0.01 
FF G-CSF (pg/ml) Multiplexed microbead assay 
(R&D Systems)b 
20.6 28.9 21.9 0.04 
FF G-GSF (pg/ml) ELISA (R&D Systems)b 127 140 135 0.5 
FF, follicular fluids.  
a Data were analysed by ANOVA, p-values for difference between no implantation and definite implantation groups are given.  
b Data are mean values. 
 
3.3. Follicular fluid G-CSF detection by multiplexed microbead assay is predictive for implantation and delivery 
rates 
To discriminate between oocytes that lead to a successful birth and those that do not, follicular fluid G-CSF was 
the only variable retained in the multivariate logistic model as significant. The Auroc was 0.77 [0.66-0.82] (p = 
0.003) for follicular fluid G-CSF evaluated by Bio-Rad multiplexed microbead assay and 0.75 [0.68-0.84] (p = 
0.004) for follicular fluid G-CSF evaluated by R&D Systems multiplexed microbead assay (Fig. 1). The optimal 
threshold according to the ROC curves for follicular fluid G-CSF was 20.54 pg/ml, with a sensitivity of 81.8% 
for a specificity of 62.3% for the Bio-Rad multiplexed microbead assay, and 24.9 pg/ml with a sensitivity of 
81.8% for a specificity of 68.6% for the R&D Systems multiplexed microbead assay. 
In contrast, for follicular fluid G-CSF quantified by ELISA, none of the data included were retained in the 
multivariate model. The Auroc for follicular fluid G-CSF evaluated by ELISA was not significant (Auroc = 0.61 
[0.52-0.70], p = 0.84) and not able to discriminate between oocytes, which will lead to delivery and those that 
did not. 
 
Fig. 1. Area under the ROC curve for follicular G-CSF assessed by multiplexed bead-based assay purchased 
from Bio-Rad and R&D Systems, and standard ELISA. 
 
 
Neither age, serum oestradiol level, the treatment day on which ovulation was triggered, nor the embryo score 
were retained in any models using multivariate logistic regression. None of the factors evaluated by multiplexed 
microbead assay were different as a function of embryo morphology, fragmentation or early cleavage. The 
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embryo morphology appeared as an independent factor in regard to follicular fluid G-CSF concentration (data 
not shown). 
However, we did observe a decrease in follicular fluid G-CSF content with each of the three methods of 
detection as a function of the oestradiol response to the hormonal stimulation. Between low, normal and high 
responders, follicular fluid G-CSF concentrations decreased from 25.3 to 21.6 pg/ml and 18.0 pg/ml with the 
R&D Systems multiplexed microbead assay, from 22.5 to 17.8 pg/ml and 19.0 pg/ml with the Bio-Rad 
multiplexed microbead assay, and from 158 to 128 pg/ml and 109 pg/ml with the G-CSF ELISA. The decrease 
was significant between low and normal responders with the Bio-Rad multiplexed microbead assay (p = 0.04) 
and the ELISA (p = 0.002). This suggests that an excessive ovarian response could induce a downregulation of 
preovulatory follicular fluid G-CSF synthesis. 
According to the optimal threshold of G-CSF concentrations defined by the ROC curve (optimal 
sensitivity/specificity) as predicting the potential for live birth, we compared the % of delivery among all the 
embryo cohorts (Table 3). Only follicular fluid G-CSF quantified by multiplexed microbead assays from either 
Bio-Rad or R&D Systems was significant in regard to the delivery rates. 
 
Table 3 Comparison of delivery rate as a function of each method of quantification of follicular fluid G-CSF, 
with the optimal threshold of concentration defined by the ROC curves. 
 Multiplexed microbead assay 
(R&D Systems) 
Multiplexed microbead assay 
(Bio-Rad) 
ELISA 
FF G-CSF (pg/ml) <24.9 >24.9 <20.54 >20.54 <149 >149 
Number of embryos 92 47 79 60 98 41 
Delivery rate (%) 11.0 24.4 9.6 24.2 13.7 20.7 
p-Valuea 0.01  0.006  0.11  
For all three methods, discriminating thresholds for follicular fluid G-CSF concentration were established from the AUroc curve and defined 
by the optimal sensitivity/specificity. The entire cohort of embryos observed was then classified as a function of follicular fluid G-CSF 
concentrations and the corresponding delivery rate values are compared.  
FF, follicular fluid.  
a Data were analysed by ANOVA, p-values for difference between delivery rates between embryos classified above and below thresholds are 
given. 
 
3.4. Comparison of follicular fluid G-CSF quantification by multiplex and single-plex G-CSF microbead assay 
In order to evaluate if multiplexing cytokine detection could have an impact on a single cytokine measurement in 
follicular fluid, we compared the quantification of follicular fluid G-CSF by multiplex versus single-plex 
microbead assay purchased from the same company (Bio-Rad) for a separate cohort of 25 undiluted follicular 
fluids collected in 2006. Follicular fluid G-CSF were highly and significantly correlated (r = 0.72, p < 0.0001) 
suggesting that detection of follicular fluid G-CSF is not influenced by the multiplex detection platform (Fig. 
2a). Compared with the recently collected follicular fluid samples, we observed an approximate 10-fold decrease 
in follicular fluid G-CSF concentrations in the 25 follicular fluids that were collected in 2006 and had undergone 
storage, transport and a few cycles of freezing and thawing before the microbead assay. 
3.5. Effect of follicular fluid dilution on follicular fluid G-CSF quantification by bead-based assay 
To document if compounds could interact and influence subsequent G-CSF quantification, we analysed the 
effect of follicular fluid dilution on subsequent quantification of G-CSF for two pooled follicular fluid samples 
previously documented to have a low versus high concentration in single-plex microbead assay. Follicular fluid 
dilution acted to influence the amount of follicular fluid G-CSF measured, and increased the detectability of 
follicular fluid G-CSF detected by single-plex microbead assay (Fig. 3). This was likely to occur through 
decreasing the concentration in samples of compounds known to bind to cytokines, such as albumin, alpha-2 
microglobulin and autoantibodies, 
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3.6. Comparison of G-CSF quantification by single-plex G-CSF microbead assay and G-CSF flow cytometric 
assay 
To evaluate if differences observed in function of each methodology applied was related mainly to antibodies 
and/or to the principles of detection, we compared the follicular fluid G-CSF concentrations observed with 
single-plex G-CSF microbead assay versus G-CSF Cytometric Bead Array flow cytometry assay. Twenty-seven 
diluted follicular fluids (1/10) with no previous thawing were simultaneously analysed. Follicular fluid G-CSF 
concentrations evaluated by single-plex microbead assay and the Cytometric Bead Array were highly correlated 
(r = 0.95, p < 0.0001) (Fig. 2b). 
 
Fig. 2. (a) Correlation between follicular fluid G-CSF evaluated by multiplex versus single-plex G-CSF 
microbead assay (both Bio-Rad) on 25 previously thawed, undiluted follicular fluid samples (r = 0.72, p < 
0.0001). (b) Correlation between follicular fluid G-CSF evaluated by single-plex G-CSF microbead based assay 









This study confirmed previous findings that G-CSF evaluation in individual follicular fluids is a non-invasive 
biomarker of oocyte competence, able to predict which oocytes will yield embryos capable of effective 
implantation. The current study highlights the importance of the methodology utilised to quantify the follicular 
fluid G-CSF. Indeed, microbead assays but not a standard commercial ELISA yielded values of follicular G-CSF 
that allow discrimination of oocytes in regard to their individual competence for future implantation. 
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The different sensitivities in the detection of the different cytokines of the three assays might be due to many 
reasons, such as the affinity or avidity of the various antibodies used, the incubation buffer, as well as variations 
in the manufacturers' recommended protocols. The clone of monoclonal antibodies used for detection and 
reporting are pivotal in obtaining identical results between assays (Elshal and McCoy, 2006) and are likely to 
explain the differences between the two microbead assay methods. Indeed, almost none of the analytes evaluated 
by either the R&D Systems or the Bio-Rad microbead assays were correlated. Factors implicated as causing 
differences are compounds known to bind to cytokines, such as albumin, alpha-2 microglobulin and 
autoantibodies (Aziz et al., 1999; de Jager et al., 2005). Consistent with this, we were able to observe a clear 
effect of dilution on subsequent quantification of follicular fluid G-CSF. Furthermore, there are substantial 
differences between microbead assay and ELISA platforms. Microbead assays use fluorescence as the reporter 
system whereas ELISA uses enzyme amplification of a colorometric substrate. Microbead assays capture ligands 
onto spherical beads in suspension while ELISA relies upon the well surface in a 96-well plate. The high 
correlation of follicular fluid G-CSF content seen between the microbead assay and flow cytometry suggests that 
ligand capture onto spherical beads, which occurs in both these methods, is an essential element in increasing 
assay sensitivity. 
The microbead assay technology has been developed for its advantages of time and cost saving due to the 
capabilities of multi-analysis in volumes as small as 50 µl. In the present application, we do not require a high 
throughput analysis of numerous analytes and do not have limited sample volume (the mean volume of 
individual follicular fluid samples is 2 ml). The cost related to purchase and maintenance of the Luminex system 
as well as the purchase of disposable kits is clearly the limitation for widespread uptake of this diagnostic assay 
into routine clinical application. 
Most authors who have compared microbead assays to ELISAs report high correlations (especially when kits 
originate from the same manufacturer), higher or lower sensitivities in various ranges of the standard curve, and 
a lack of agreement between the computed absolute protein values, as observed here (Dupont et al., 2005; Elshal 
and McCoy, 2006; Pickering et al., 2002; Young et al., 2008). A key concern is the possibility that multiplexing 
itself results in anomalies in the quantification of some of the analytes. The high correlation we observed 
between multiplex and single-plex microbead assay data indicates that multiplexing is not necessary for 
follicular fluid G-CSF quantification in follicular fluid. 
To apply this test to a routine clinical setting, standard operating procedures will need to be fully documented 
and validated through inter-laboratory comparisons. The importance of sample collection, processing and storage 
in affecting the validity of the measurement and levels of cytokines in biological fluids has been demonstrated 
(Aziz et al., 1999). Dilution of samples may be suitable for optimal quantification, especially for low 
concentrations. We also observed that in comparison with previous studies, the detection threshold depends on 
the lot number of the microbead assay, suggesting that uniformity in the standards for quantitative assays is 
required. For example, appropriately stored aliquots of pooled follicular fluids might be used as inter-run 
calibrators. 
To conclude, follicular fluid G-CSF appears to be a non-invasive biomarker of human oocyte developmental 
competence. Since the comparison of absolute values is crucial for effective consequences in the choice of 
embryos, designing a quick, routine test, which displays an optimal sensitivity and a high specificity is now an 
absolute requirement. 
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